Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcomaMichelle Chadwick(Cincinnati Children's Hospital Medical Center), Lionel M.L. Chow(Wright State University)OncotargetMay 15, 201810.18632/oncotarget.25345Cited by 27SaveCiteExport RISWatch citationsRelated PapersThe transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas|Neuro-Oncology|2016|38